Entomophthoromycosis: A Systematic Analysis of 405 cases

Clicks: 35
ID: 327793
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #111 of 187 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 187 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Entomophthoromycosis is a chronic fungal granulomatous disease caused by Basidiobolus and Conidiobolus species. This disease is associated with significant morbidity and prolonged treatment. This systematic review aims to address the epidemiology, clinical features, diagnostic methods, therapeutic strategies, and clinical outcomes of entomophthoromycosis. Medline, Embase, Scopus and Web of Science databases were searched using appropriate keywords for entomophthoromycosis from 1 January 2000 to 31 December 2023. A total of 405 cases of entomophthoromycosis were included; of those, Basidiobolomycosis (n=241/405, 59.5%) was the most common, followed by conidiobolomycosis (n=123/405, 30.4%) and unclassified entomophthoromycosis (n=41/405, 10.1%). Distinct epidemiological patterns were observed: basidiobolomycosis was most commonly reported from Middle Eastern countries (n=139/241, 57.7%), whereas conidiobolomycosis was most commonly reported from Southeast Asian countries (n=97/123, 78.9%). The common clinical forms seen in basidiobolomycosis were gastrointestinal (n=164/241, 68%) and cutaneous (n=64/241, 26.6%) disease, and rhino-facial disease (n=114/123, 92.7%) in conidiobolomycosis. Demonstration of fungal hyphae by histopathology or by direct microscopy is the most common diagnostic method (n=377/405, 93.1%). Culture positivity was higher in conidiobolomycosis (n=94/123, 76.4%) than in basidiobolomycosis (n=108/241, 44.8%). Antifungal treatment with surgery (n=129/231, 55.8%) was the common treatment strategy for basidiobolomycosis. Antifungal therapy alone (n=77/112, 68.8%) was the most commonly used treatment for conidiobolomycosis. Itraconazole was the most common antifungal used in treatment (n=228/357, 63.9%), followed by potassium iodide (n=104/357, 29.1%). Overall mortality of the cohort is 10.93% (n=40/366). Gastrointestinal basidiobolomycosis has a higher mortality (n=28/150, 18.7%). Both these diseases exhibit different geographic patterns and clinical forms. The disease mimics malignancies and other inflammatory diseases; high clinical suspicion is essential for prompt diagnosis and initiation of therapy to improve clinical outcomes.
Reference Key
openalex_W7211928226 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dinesh Reddy Gangavaram, Snigdha Reddy, Kalaiselvi Vinayagamoorthy, Hariprasath Prakash
Are you one of these authors? Claim your profile
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag097
URL
https://doi.org/10.1093/mmy/myag097
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.